PF-Atlas › Clinical Trials › NCT01737983
Effect of Lactobacillus Reuteri in Cystic Fibrosis
Lactobacillus reuteri · Phase 4
Registry ID
NCT01737983
Phase
Phase 4
Status
Completed
Drug / intervention
Lactobacillus reuteri
Sponsor
Azienda Policlinico Umberto I
Start
2009-05
About this trial
Lactobacillus reuteri is evaluated in NCT01737983, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Azienda Policlinico Umberto I. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01737983 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.